₹223.38
Above FV▼ -30.9% against the close used
Model range ₹36.52 – ₹390.37
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹36.52Fair value₹223.38Bull₹390.37
FairClose
52-week traded range
52W low ₹296.7552W high ₹571.15
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Medi Assist Health Ser L closed at ₹323.05, 44.6% above the consensus fair value of ₹223.38 drawn from 9 valuation models.
Financial DNA score 53/100 — Good. P/E of 23.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹119.76
-62.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=3.1%, r=10%, tg=3%, n=10yr
Graham Number
₹184.70
-42.8%
√(22.5 × EPS × BVPS)
EPS=11.78, BVPS=128.71 · outside Graham range (P/E 23.9, P/B 2.5) — asset-light, treat as a rough floor
Graham Formula
₹160.80
-50.2%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=3.1%, FD=7%
P/E Fair Value
₹281.54
-12.8%
EPS × 23.9x (sector P/E)
EPS=11.78, Sector P/E=23.9x
Peter Lynch (PEG)
₹36.52
-88.7%
EPS × Growth% (PEG = 1 is fair)
EPS=11.78, g=3.1%
EV/EBITDA
₹390.37
+20.8%
(EBITDA × 11.6x − Net Debt) ÷ Shares
EBITDA=2.52B
Book Value (P/B)
₹201.45
-37.6%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=128.71, ROE=13.9%, g=3.1%, r=10%
Reverse DCF
₹323.05
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.4% | Historical: 3.1%
Margin of Safety
₹140.02
-56.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=186.7, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.